Constellium SE
CSTMBasic MaterialsNASDAQAluminum · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the basic materials sector, Constellium SE focuses on Aluminum services and products. Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial. With a market capitalization of $3.15B, it sits in mid-cap territory. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Market Cap
$3.15B
Beta
1.57
P/E (TTM)
6.00
P/E (Fwd)
7.90
EPS (TTM)
$3.87
EPS (Fwd)
$2.94
ROE
53.1%
ROA
9.9%
Cash
$163.0M
Total Debt
$1.92B
Free CF
$53.6M
52W Change
37.8%
Annual Financials
Cash vs Debt
Where CSTM stands vs its 150-day and 200-day moving averages
As of the October 8, 2026 close, CSTM finished 12.68% below its 150-day moving average ($29.11) and 7.63% below its 200-day moving average ($27.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CSTM overbought or oversold?
At the October 8, 2026 close, CSTM's RSI(14) was 41.3, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, CSTM has $163.0M in cash with $1.92B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $53.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 53.1% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.9% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $8.53B (2022) to $8.45B (2025).
Constellium SE's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Constellium SE carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CSTM's risk profile alongside its fundamentals and technical indicators provides a more complete picture.